Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Mapping utility scores from the Barthel index.

Kaambwa B, Billingham L, Bryan S.

Eur J Health Econ. 2013 Apr;14(2):231-41. doi: 10.1007/s10198-011-0364-5. Epub 2011 Nov 2.

PMID:
22045272
2.

Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.

Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.

Med Decis Making. 2010 May-Jun;30(3):341-54. doi: 10.1177/0272989X09349961. Epub 2009 Oct 26.

PMID:
19858500
3.

Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.

Hawton A, Green C, Telford C, Zajicek J, Wright D.

Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.

4.

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.

Teckle P, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, Peacock S.

Health Qual Life Outcomes. 2013 Dec 1;11:203. doi: 10.1186/1477-7525-11-203.

5.

Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.

Kim HL, Kim D, Jang EJ, Lee MY, Song HJ, Park SY, Cho SK, Sung YK, Choi CB, Won S, Bang SY, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Kim J, Kim SK, Kim TH, Kim TJ, Koh E, Lee H, Lee HS, Lee J, Lee SS, Lee SW, Park SH, Shim SC, Yoo DH, Yoon BY, Bae SC, Lee EK.

Rheumatol Int. 2016 Apr;36(4):505-13. doi: 10.1007/s00296-016-3427-1. Epub 2016 Feb 6.

PMID:
26849891
6.

Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.

Wong CKH, Cheung PWH, Samartzis D, Luk KD, Cheung KMC, Lam CLK, Cheung JPY.

PLoS One. 2017 Apr 17;12(4):e0175847. doi: 10.1371/journal.pone.0175847. eCollection 2017.

7.

Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.

Xie F, Pullenayegum EM, Li SC, Hopkins R, Thumboo J, Lo NN.

Value Health. 2010 Dec;13(8):873-8. doi: 10.1111/j.1524-4733.2010.00770.x. Erratum in: Value Health. 2011 Jun;14(4):620.

8.

Probabilistic mapping of the health status measure SF-12 onto the health utility measure EQ-5D using the US-population-based scoring models.

Le QA.

Qual Life Res. 2014 Mar;23(2):459-66. doi: 10.1007/s11136-013-0517-3. Epub 2013 Sep 13.

PMID:
24026631
9.

Mapping EQ-5D utility scores from the PedsQLâ„¢ generic core scales.

Khan KA, Petrou S, Rivero-Arias O, Walters SJ, Boyle SE.

Pharmacoeconomics. 2014 Jul;32(7):693-706. doi: 10.1007/s40273-014-0153-y.

PMID:
24715604
10.

Mapping the COPD Assessment Test onto EQ-5D.

Hoyle CK, Tabberer M, Brooks J.

Value Health. 2016 Jun;19(4):469-77. doi: 10.1016/j.jval.2016.01.005. Epub 2016 Apr 1.

11.

Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.

Franklin M, Payne K, Elliott RA.

Med Decis Making. 2018 Jan;38(1):79-94. doi: 10.1177/0272989X17732975. Epub 2017 Oct 23.

PMID:
29056069
12.

Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights.

Askew RL, Swartz RJ, Xing Y, Cantor SB, Ross MI, Gershenwald JE, Palmer JL, Lee JE, Cormier JN.

Value Health. 2011 Sep-Oct;14(6):900-6. doi: 10.1016/j.jval.2011.04.003. Epub 2011 Jun 24.

13.

Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.

Wolfe F, Michaud K, Wallenstein G.

J Rheumatol. 2010 Aug 1;37(8):1615-25. doi: 10.3899/jrheum.100043. Epub 2010 Jun 15. Erratum in: J Rheumatol. 2010 Sep;37(9):1979.

PMID:
20551106
14.

Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.

Dakin H, Gray A, Murray D.

Qual Life Res. 2013 Apr;22(3):683-94. doi: 10.1007/s11136-012-0189-4. Epub 2012 May 4.

15.

Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population.

Kim SH, Kim SO, Lee SI, Jo MW.

Health Qual Life Outcomes. 2014 Sep 24;12:145. doi: 10.1186/s12955-014-0145-9.

17.

Mapping health outcome measures from a stroke registry to EQ-5D weights.

Ghatnekar O, Eriksson M, Glader EL.

Health Qual Life Outcomes. 2013 Mar 7;11:34. doi: 10.1186/1477-7525-11-34.

18.

Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.

Doble B, Lorgelly P.

Qual Life Res. 2016 Apr;25(4):891-911. doi: 10.1007/s11136-015-1116-2. Epub 2015 Sep 21.

PMID:
26391884
19.

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.

Gray AM, Rivero-Arias O, Clarke PM.

Med Decis Making. 2006 Jan-Feb;26(1):18-29.

PMID:
16495197
20.

Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration.

Payakachat N, Summers KH, Pleil AM, Murawski MM, Thomas J 3rd, Jennings K, Anderson JG.

Qual Life Res. 2009 Sep;18(7):801-13. doi: 10.1007/s11136-009-9499-6. Epub 2009 Jun 19.

PMID:
19543808

Supplemental Content

Support Center